Abstract Library

Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.

Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.

ENETS Abstract Search

#2287 Mitochondrial or Aerobic Glycolysis Oriented Metabolism May Define Pancreatic Neuroendocrine Tumors (PanNET) Resistance to mTOR-Targeting Therapies

Introduction: The mTOR inhibitor Everolimus is approved for the treatment of PanNET and no predictive biomarker is available. mTOR is a central node controlling mitochondrial and aerobic glycolytic metabolisms.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Cros J, Bucau M, Raffenne J, Soukeur M, Dumont F,

Keywords: mTOR, everolimus, pancreatic NET, metabolism,

#707 Neuroendocrine Carcinoma: Surgery of Peritoneal Metastasis

Introduction: Neuroendocrine tumor (NET)-derived peritoneal metastases (PM) are not really described nor taken into account in the literature, yet they exert an impact on overall survival (OS)

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author: Dumont F

Authors: Elias D, David A, Sourouille I, Honoré C, Goéré D,

Keywords: neuroendocrine tumor, peritoneal metastases, hyperthermic intraperitoneal chemotherapy,

#706 Is There a Therapeutic Impact of Segmental Portal Hypertension on Advanced Pancreatic Neuroendocrine Tumors?

Introduction: Well-differenciated locally advanced Pancreatic Neuroendocrine Tumors (PNET) lead to significant local complications due to segmental portal hypertension (SPH).

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author: Dumont F

Authors: Goudard Y, Dumont F, Caramella C, Goéré D, Honoré C,

Keywords: pancreatic neuroendocrine tumors, segmental portal hypertension, locally advanced,